Scienture Holdings, Inc. SCNX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-02-18
Scienture Holdings, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 76.8% | 4.4% | 3.6% | 53.8% | 48.0% | 33.3% | 65.5% | 88.3% | 100.0% | 100.0% |
| Operating margin | -9867.9% | -10758.7% | -322.4% | -28.4% | -53.5% | -14.6% | 1.7% | -2.3% | 13.5% | -40.6% |
| Net margin | -9618.0% | 6634.7% | -1308.3% | -33.9% | -53.8% | -14.8% | -3.8% | 0.2% | 9.9% | -111.2% |
| FCF margin | — | -10448.6% | — | — | -26.2% | -13.2% | — | — | — | — |
| Return on assets | -49.3% | 8.6% | -142.4% | -93.6% | -92.2% | -25.9% | -5.1% | 0.4% | 46.8% | -818.7% |
| Return on equity | -59.2% | 11.5% | -3290.0% | -455.0% | -141.0% | -29.2% | -6.9% | 1.1% | -92.6% | 240.4% |
| Debt / equity | — | 0.04× | — | — | — | — | 0.05× | 0.62× | -2.14× | — |
| Current ratio | 2.89 | 0.80 | 0.24 | 0.98 | 4.72 | 10.95 | 7.30 | 1.70 | 1.16 | 0.23 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.